| Nancy Kay Peterson-holt, LMFT | |
|
45-521 Kapalai Rd, Kaneohe, HI 96744-2903 | |
| (808) 366-1947 | |
| Not Available |
| Full Name | Nancy Kay Peterson-holt |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 45-521 Kapalai Rd, Kaneohe, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871101717 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | LMFT34388 (California) | Secondary |
| 106H00000X | Marriage & Family Therapist | MFT683 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Kay Peterson-holt, LMFT 45-521 Kapalai Rd, Kaneohe, HI 96744-2903 Ph: (808) 366-1947 | Nancy Kay Peterson-holt, LMFT 45-521 Kapalai Rd, Kaneohe, HI 96744-2903 Ph: (808) 366-1947 |
News Archive
Hooper Holmes today announced financial results for the quarter ended March 31, 2012.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
A Case Western Reserve University School of Medicine researcher has compiled evidence from more than 100 publications to show how obesity increases risk of 13 different cancers in young adults.
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
› Verified 1 days ago
Angelique Matutino, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 45-845 Pookela St, Kaneohe, HI 96744 Phone: 808-447-5261 Fax: 808-236-2626 | |
Jana-macy Moya, M.S. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 45-454 Koa Kahiko St, Kaneohe, HI 96744 Phone: 808-780-1850 | |
Jeanne Teleia, M.S., LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 47-669 Melekula Rd, #10, Kaneohe, HI 96744 Phone: 808-224-5008 Fax: 866-886-1743 | |
Miss Eren Misa Kamiyama, MFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 45-270 William Henry Rd Ste 207, Kaneohe, HI 96744 Phone: 808-391-3736 | |
Mrs. Tracy Opal Mansson, M.A. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 44-735 Hoonani Pl, Kaneohe, HI 96744 Phone: 808-292-8560 | |
Kali Ikemoto, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 45-112 Leleua Pl, Kaneohe, HI 96744 Phone: 808-292-9882 | |
Mr. Jeffrie L Wagner, MFT, CSAC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 46-050 Konane Pl, Kaneohe, HI 96744 Phone: 808-247-7962 |